US 11802283
Oligonucleotide analogues targeting human LMNA
granted A61PA61P43/00
Quick answer
US patent 11802283 (Oligonucleotide analogues targeting human LMNA) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P43/00